|
⚲
|
| Keyboard |
| Ampersand 2018 Limited Partnership
✚
|
|
|---|---|
| CIK # | 0001734267 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001734267] | |
| 4 | [0001734267] | |
| D | [0001734267] | |
| SC 13D | [0001734267] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Ampersand 2018 Limited Partnership | Interpace Diagnostics Group Inc | [2019-07-25] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Interpace Biosciences Inc | |
| Ampersand 2018 Limited Partnership |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Interpace Biosciences Inc IDXG
Common Stock
|
2026-01-20 | Conversion | 13,861,386 | $2.02 | 28,000,000 |
|
Interpace Biosciences Inc IDXG
Series C Convertible Preferred Stock · derivative
|
2026-01-20 | Conversion | 28,000 | $0.00 | |
|
Interpace Biosciences Inc IDXG
Series C Convertible Preferred Stock · derivative
|
2024-10-11 | Grant | 28,000 | ||
|
Interpace Biosciences Inc IDXG
Series B Convertible Preferred Stock · derivative
|
2024-10-11 | Disposed to issuer | 28,000 | ||
|
Interpace Biosciences Inc IDXG
Series B Convertible Preferred Stock · derivative
|
2020-01-15 | Grant | 1,000 | $1,000.00 | 1,000,000 |
|
Interpace Biosciences Inc IDXG
Series B Convertible Preferred Stock · derivative
|
2020-01-15 | Grant | 27,000 | ||
|
Interpace Biosciences Inc IDXG
Series A Convertible Preferred Stock · derivative
|
2020-01-15 | Disposed to issuer | 270 | ||
|
Interpace Biosciences Inc IDXG
Series A Convertible Preferred Stock · derivative
|
2019-10-16 | Grant | 130 | $100,000.00 | 13,000,000 |
|
Interpace Biosciences Inc IDXG
Series A-1 Convertible Preferred Stock · derivative
|
2019-10-10 | Disposed to issuer | 80 | $0.00 | |
|
Interpace Biosciences Inc IDXG
Series A Convertible Preferred Stock · derivative
|
2019-10-10 | Grant | 80 | $0.00 |